These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3978999)

  • 1. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
    Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
    Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.
    Davison R; Parker M; Atkinson AJ
    Am Heart J; 1982 Aug; 104(2 Pt 1):203-8. PubMed ID: 7102503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
    Sawyer DR; Ludden TM; Crawford MH
    Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program.
    Pfeifer HJ; Greenblatt DJ; Koch-Weser J
    Am Heart J; 1976 Aug; 92(2):168-73. PubMed ID: 941829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lidocaine elimination and dose adjustment in acute heart infarct and heart insufficiency].
    Kettner W; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Jul; 39(14):335-42. PubMed ID: 6485432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting free (unbound) lignocaine concentration in suspected acute myocardial infarction.
    Routledge PA; Stargel WW; Barchowsky A; Wagner GS; Shand DG
    Br J Clin Pharmacol; 1989 Nov; 28(5):593-7. PubMed ID: 2590613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of lidocaine after intramuscular injection and subsequent infusion in patients with acute myocardial infarction.
    Oltmanns D; Lübben C; Pentz R; Siegers CP
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):582-4. PubMed ID: 7152740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic principles of lidocaine dosing in relation to disease state.
    Waller ES
    J Clin Pharmacol; 1981 Apr; 21(4):181-94. PubMed ID: 7240439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-pressure liquid chromatographic determination of lidocaine and its active deethylated metabolites.
    Hill J; Roussin A; Lelorier J; Caille G
    J Pharm Sci; 1980 Nov; 69(11):1341-3. PubMed ID: 7452468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
    Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M
    Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lidocaine, monoethylglycinexylidide, and glycinexylidide concentrations after epidural administration in geriatric patients.
    Fukuda T; Kakiuchi Y; Miyabe M; Okubo N; Yaguchi Y; Kohda Y; Toyooka H
    Reg Anesth Pain Med; 2000; 25(3):268-73. PubMed ID: 10834781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
    Fredrick DS; Boersma RB
    Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of lignocaine.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of lidocaine and its metabolites after prolonged infusion in healthy horses.
    Dickey EJ; McKenzie HC; Brown KA; de Solis CN
    Equine Vet J; 2008 Jun; 40(4):348-52. PubMed ID: 18267881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
    Nattel S; Gagne G; Pineau M
    Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction.
    LeLorier J; Grenon D; Latour Y; Caillé G; Dumont G; Brosseau A; Solignac A
    Ann Intern Med; 1977 Dec; 87(6):700-2. PubMed ID: 931206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages.
    Drayer DE; Lorenzo B; Werns S; Reidenberg MM
    Clin Pharmacol Ther; 1983 Jul; 34(1):14-22. PubMed ID: 6861434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.